Neurocrine Biosciences reported $300.1M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Acorda Therapeutics ACOR:US USD 38.5M 6.47M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Amgen AMGN:US USD 3.91B 504M
Aptinyx Inc APTX:US USD 14.66M 2.45M
Biogen BIIB:US USD 1.19B 1.45B
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Cytokinetics CYTK:US USD 133.2M 33.36M
Dynavax Technologies DVAX:US USD 106.34M 21.9M
Enanta Pharmaceuticals ENTA:US USD 47.36M 4.65M
Exelixis EXEL:US USD 329.12M 6.6M
Gilead Sciences GILD:US USD 4.2B 26M
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
Intra Cellular Therapies ITCI:US USD 127.5M 16M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Pfizer PFE:US USD 13.23B 2.41B
Prothena PRTA:US USD 51.85M 7.33M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Repligen RGEN:US USD 148.08M 3.61M
Rigel Pharmaceuticals RIGL:US USD 40.81M 1.97M
Sarepta Therapeutics SRPT:US USD 487.06M 42.45M
Teva Pharmaceutical TEVA:IT USD 3.18B 1.56B
Ultragenyx Pharmaceutical RARE:US USD 315.77M 84.83M
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M
Xoma XOMA:US USD 4.82M 927K
YTE INCY:US USD 684.93M 27.96M